Literature DB >> 7657657

Cyclic adenosine monophosphate can convert epidermal growth factor into a differentiating factor in neuronal cells.

H Yao1, K Labudda, C Rim, P Capodieci, M Loda, P J Stork.   

Abstract

The rat pheochromocytoma (PC12) cell line is a model for studying the mechanism of growth factor action. Both epidermal growth factor and nerve growth factor stimulate mitogen-activated protein (MAP) kinase in these cells. Recent data suggest that the transient activation of MAP kinase may trigger proliferation, whereas sustained activation triggers differentiation in these cells. We have tested this model by asking whether agents that stimulate MAP kinase without inducing differentiation can act additively to trigger differentiation. Neither forskolin nor epidermal growth factor can stimulate differentiation, yet both activate MAP kinase in these cells. Together, their actions on MAP kinase are synergistic. Cells treated with both agents differentiate, measured morphologically and by the induction of neural-specific genes. We propose that cellular responses to growth factor action are dependent not only on the activation of growth factor receptors by specific growth factors but on synchronous signals that may elevate MAP kinase levels within the same cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7657657     DOI: 10.1074/jbc.270.35.20748

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Both protein kinase A and mitogen-activated protein kinase are required in the amygdala for the macromolecular synthesis-dependent late phase of long-term potentiation.

Authors:  Y Y Huang; K C Martin; E R Kandel
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

2.  A novel role for FGF and extracellular signal-regulated kinase in gap junction-mediated intercellular communication in the lens.

Authors:  A C Le; L S Musil
Journal:  J Cell Biol       Date:  2001-07-09       Impact factor: 10.539

3.  Epac activation converts cAMP from a proliferative into a differentiation signal in PC12 cells.

Authors:  Simone Kiermayer; Ricardo M Biondi; Jochen Imig; Guido Plotz; Jörg Haupenthal; Stefan Zeuzem; Albrecht Piiper
Journal:  Mol Biol Cell       Date:  2005-10-05       Impact factor: 4.138

4.  cAMP and EPAC Signaling Functionally Replace OCT4 During Induced Pluripotent Stem Cell Reprogramming.

Authors:  Ashley L Fritz; Maroof M Adil; Sunnie R Mao; David V Schaffer
Journal:  Mol Ther       Date:  2015-02-10       Impact factor: 11.454

5.  Role of the bZIP transcription factor IREBF1 in the NGF induction of stromelysin-1 (transin) gene expression in PC12 cells.

Authors:  S deSouza; L A Nordstrom; G Ciment
Journal:  J Mol Neurosci       Date:  1997-06       Impact factor: 3.444

6.  Spatiotemporally regulated protein kinase A activity is a critical regulator of growth factor-stimulated extracellular signal-regulated kinase signaling in PC12 cells.

Authors:  Katie J Herbst; Michael D Allen; Jin Zhang
Journal:  Mol Cell Biol       Date:  2011-08-01       Impact factor: 4.272

7.  High constitutive NF-kappaB activity mediates resistance to oxidative stress in neuronal cells.

Authors:  F Lezoualc'h; Y Sagara; F Holsboer; C Behl
Journal:  J Neurosci       Date:  1998-05-01       Impact factor: 6.167

8.  Mitogen-activated protein kinase regulates early phosphorylation and delayed expression of Ca2+/calmodulin-dependent protein kinase II in long-term potentiation.

Authors:  M G Giovannini; R D Blitzer; T Wong; K Asoma; P Tsokas; J H Morrison; R Iyengar; E M Landau
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

Review 9.  EPAC proteins transduce diverse cellular actions of cAMP.

Authors:  Gillian Borland; Brian O Smith; Stephen J Yarwood
Journal:  Br J Pharmacol       Date:  2009-02-06       Impact factor: 8.739

10.  Upregulation and maintenance of gap junctional communication in lens cells.

Authors:  Bruce A Boswell; Anh-Chi N Le; Linda S Musil
Journal:  Exp Eye Res       Date:  2008-12-11       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.